Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Prostate Cancer | Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer

53:21
 
Distribuie
 

Manage episode 432164457 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Featuring an interview with Dr Matthew R Smith, including the following topics:

  • Selection and sequencing of androgen-targeting therapies (0:00)
  • Evidence-based selection of treatment for metastatic hormone-sensitive prostate cancer (25:07)
  • New considerations with the use of PARP inhibitors for metastatic castration-resistant prostate cancer (mCRPC) (27:44)
  • Role of novel radiopharmaceuticals for mCRPC (37:09)
  • Promising investigational approaches for prostate cancer (42:38)

CME information and select publications

  continue reading

1457 episoade

Artwork
iconDistribuie
 
Manage episode 432164457 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Featuring an interview with Dr Matthew R Smith, including the following topics:

  • Selection and sequencing of androgen-targeting therapies (0:00)
  • Evidence-based selection of treatment for metastatic hormone-sensitive prostate cancer (25:07)
  • New considerations with the use of PARP inhibitors for metastatic castration-resistant prostate cancer (mCRPC) (27:44)
  • Role of novel radiopharmaceuticals for mCRPC (37:09)
  • Promising investigational approaches for prostate cancer (42:38)

CME information and select publications

  continue reading

1457 episoade

Усі епізоди

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință